{
  "id": 2631,
  "text": "A guide to essential practice.Second edition.http://www.who.int/reproductivehealth /publications/cancers/cervical-cancerguide/en/ (2014).427.Hou, J., et al.Risk factors for poor prognosis in microinvasive adenocarcinoma of the uterine cervix (IA1 and IA2): a pooled analysis.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: A guide to essential practice.Second edition.http://www.who.int/reproductivehealth /publications/cancers/cervical-cancerguide/en/ (2014).427.Hou, J., et al.Risk factors for poor prognosis in microinvasive adenocarcinoma of the uterine cervix (IA1 and IA2): a pooled analysis.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "宫颈癌的微浸润腺癌（IA1和IA2）与其他宫颈癌亚型相比，通常预后较好，但仍存在一些风险因素可能影响其预后。其中包括以下几点：\n\n1. **肿瘤浸润深度**：在IA1和IA2阶段，虽然侵润较浅，但更大的浸润深度可能增加复发的风险。\n\n2. **淋巴血管浸润（LVSI）**：是否存在淋巴血管浸润是评估预后的重要指标。LVSI存在与淋巴结转移风险增加相关联，可能导致较差的预后。\n\n3. **肿瘤分化程度**：较差的分化可能预示着更具侵袭性的生物学行为，从而影响疾病的进展和预后。\n\n4. **年龄**：患者年龄较大可能与更差的预后相关，需特别关注老年患者的治疗方案调整。\n\n5. **术后残余肿瘤**：手术后是否存在残余肿瘤组织是影响复发和预后的重要因素。\n\n针对这些风险因素，在诊断和制定治疗方案时，需进行全面的评估，以优化患者的治疗效果和预后。对于每位患者，应根据个体情况进行详细讨论，以提供最适合的治疗建议。",
  "query": "宫颈癌的微浸润腺癌（IA1和IA2）不良预后的风险因素有哪些？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 宫颈癌的微浸润腺癌（IA1和IA2）不良预后的风险因素有哪些？\n\n<reference text>: A guide to essential practice.Second edition.http://www.who.int/reproductivehealth /publications/cancers/cervical-cancerguide/en/ (2014).427.Hou, J., et al.Risk factors for poor prognosis in microinvasive adenocarcinoma of the uterine cervix (IA1 and IA2): a pooled analysis.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "宫颈癌的微浸润腺癌（IA1和IA2）与其他宫颈癌亚型相比，通常预后较好，但仍存在一些风险因素可能影响其预后。其中包括以下几点：\n\n1. **肿瘤浸润深度**：在IA1和IA2阶段，虽然侵润较浅，但更大的浸润深度可能增加复发的风险。\n\n2. **淋巴血管浸润（LVSI）**：是否存在淋巴血管浸润是评估预后的重要指标。LVSI存在与淋巴结转移风险增加相关联，可能导致较差的预后。\n\n3. **肿瘤分化程度**：较差的分化可能预示着更具侵袭性的生物学行为，从而影响疾病的进展和预后。\n\n4. **年龄**：患者年龄较大可能与更差的预后相关，需特别关注老年患者的治疗方案调整。\n\n5. **术后残余肿瘤**：手术后是否存在残余肿瘤组织是影响复发和预后的重要因素。\n\n针对这些风险因素，在诊断和制定治疗方案时，需进行全面的评估，以优化患者的治疗效果和预后。对于每位患者，应根据个体情况进行详细讨论，以提供最适合的治疗建议。"
}